Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Appendix F
Characteristics of Neisseria and Related Species of Human Origin*
Laboratory Guidelines for Screening To Detect Chlamydia
trachomatis
and Neisseria gonorrhoeae Infections — 2002
Consultants
External Consultants: Association of Public Health Laboratories,
Washington, D.C. (no reviewers identified); Dana Best, M.D., Agency for
Healthcare Research and Quality, Rockville, Maryland; Margaret C. Fisher,
M.D., and Leonard Weiner, M.D., American Academy of Pediatrics, Elk Grove
Village, Illinois; Luella Klein, M.D., American College of Obstetricians
and Gynecologists, Washington, D.C.; Roxanne Shively, Food and Drug
Administration, Rockville, Maryland; Aggie Clark, University of
Washington, Seattle, Washington; Dennis V. Ferrero, M.P.H., San Joaquin
County Regional Public Health Laboratory, Stockton, California; Charlotte
A. Gaydos, Dr.P.H., Johns Hopkins University, Baltimore, Maryland; Anne
Haddix, Ph.D., Emory University, Atlanta, Georgia; Margaret R.
Hammerschlag, M.D., State University of New York, Brooklyn, New York; Doug
R. Harger, Oregon Health Division, Portland, Oregon; Edward W. Hook, III,
M.D., University of Alabama at Birmingham, Birmingham, Alabama; J. Mehsen
Joseph, Ph.D., Maryland Department of Health and Mental Hygiene,
Baltimore, Maryland; Robert B. Jones, M.D., Ph.D., Indiana University,
Indianapolis, Indiana; James A. Kellogg, Ph.D., York Hospital, York,
Pennsylvania; Barry P. Katz, Ph.D., Indiana University, Indianapolis,
Indiana; David H. Martin, M.D., Louisiana State University, New Orleans,
Louisiana; Toby Merlin, M.D., Lovelace Health Systems and CIGNA Healthcare
of Arizona, Albuquerque, New Mexico; William C. Miller, M.D., Ph.D.,
University of North Carolina, Chapel Hill, North Carolina; Pamela G.
Nathanson, Family Planning Council, Inc., Philadelphia, Pennsylvania;
Albert Rabinovitch, M.D., Ph.D., Specialty Laboratories, Inc., Santa
Monica, California; Julius Schachter, Ph.D., University of California at
San Francisco, San Francisco, California; Karla Schmitt, Ph.D., Florida
Department of Health, Tallahassee, Florida; Michael R. Skeels, Ph.D.,
Oregon State Public Health Laboratories, Portland, Oregon; Walter E. Stamm,
M.D., University of Washington, Seattle, Washington; Barbara van der Pol,
Indiana University, Indianapolis, Indiana; Jo Ann Yatabe, Ph.D., Specialty
Laboratories, Inc., Santa Monica, California.
CDC Consultants: Timothy A. Green, Ph.D., Epidemiology Program Office,
John R. Astles, Ph.D., Nancy L. Anderson, M.M.Sc., and Rhonda S. Whalen,
M.S., Public Health Practice Program Office.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
